| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/31/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 265 | $42.33 | $11.2k | | 07/31/2023 |
| 07/07/2023 | CYTOKINETICS INC | CYTK | Sale | Common Stock | 2k | $34.12 | $68.2k | | 07/07/2023 |
| 07/06/2023 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 1.9k | $39.30 | $73.4k | | 07/06/2023 |
| 06/15/2023 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 49.2k | $3.92 | $193k | | 06/15/2023 |
| 06/14/2023 | Intellia Therapeutics, Inc. | NTLA | Grant | | 4.4k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 6.5k | $45.20 | $292.6k | | 06/14/2023 |
| 05/30/2023 | VERACYTE, INC. | VCYT | Sale | Common Stock | 1.5k | $25.91 | $39.9k | | 05/30/2023 |
| 05/10/2023 | CYTOKINETICS INC | CYTK | Grant | Common Stock | 5k | $0.00 | $0 | | 05/10/2023 |
| 05/10/2023 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (Right to Buy) | 10k | $37.89 | $378.9k | | 05/10/2023 |
| 10/03/2022 | CYTOKINETICS INC | CYTK | Grant | Common Stock | 220 | $51.11 | $11.2k | | 10/03/2022 |
| 07/01/2022 | CYTOKINETICS INC | CYTK | Grant | Common Stock | 274 | $41.00 | $11.2k | | 07/01/2022 |
| 06/16/2022 | VERACYTE, INC. | VCYT | Grant | Common Stock | 14.7k | $0.00 | $0 | | 06/16/2022 |
| 06/15/2022 | ARDELYX, INC. | ARDX | Grant | Common Stock | 95.8k | $0.00 | $0 | | 06/15/2022 |
| 06/15/2022 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 100k | $0.55 | $54.8k | | 06/15/2022 |
| 06/14/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | | 2k | $0.00 | $0 | | 06/14/2022 |
| 06/14/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 3k | $38.49 | $114.7k | | 06/14/2022 |
| 05/10/2022 | CYTOKINETICS INC | CYTK | Grant | Common Stock | 5k | $0.00 | $0 | | 05/10/2022 |
| 05/10/2022 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (right to buy) | 10k | $37.89 | $378.9k | | 05/10/2022 |
| 04/28/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | | 8k | $0.00 | $0 | | 04/28/2022 |
| 04/28/2022 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (Right to Buy) | 11.7k | $50.29 | $588.4k | | 04/28/2022 |
| 04/01/2022 | CYTOKINETICS INC | CYTK | Grant | Common Stock | 293 | $38.38 | $11.2k | | 04/01/2022 |
| 01/03/2022 | CYTOKINETICS INC | CYTK | Grant | Common Stock | 244 | $46.00 | $11.2k | | 01/03/2022 |
| 05/12/2021 | CYTOKINETICS INC | CYTK | Grant | Common Stock | 5k | $0.00 | $0 | | 05/12/2021 |
| 05/12/2021 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (right to buy) | 10k | $24.32 | $243.2k | | 05/12/2021 |
| 03/19/2021 | VERACYTE, INC. | VCYT | Grant | Common Stock | 11.5k | $0.00 | $0 | | 03/19/2021 |
| 03/11/2021 | ARDELYX, INC. | ARDX | Grant | Stock Option (Right to Buy) | 63.7k | $7.01 | $446.4k | | 03/11/2021 |
| 02/17/2021 | CYTOKINETICS INC | CYTK | Grant | Non-Qualified Stock Option (right to buy) | 35k | $21.86 | $765.1k | | 02/17/2021 |